- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| TERN | Terns Pharmaceuticals Inc | 5.85% | 1,334,418 | $70,350,517 | -4,012,510 | -75.04% | $52.72 | 13F |
| DYN | Dyne Therapeutics Inc | 2.35% | 1,557,466 | $28,236,859 | -1,057,494 | -40.44% | $18.13 | 13F |
| ABVX | Abivax SA - ADR | 2.22% | 239,539 | $26,672,668 | -119,766 | -33.33% | $111.35 | 13F |
| ACRS | Aclaris Therapeutics, Inc. | 2.08% | 6,666,666 | $24,999,998 | -2,222,222 | -25% | $3.75 | 13F |
| ORIC | Oric Pharmaceuticals Inc | 1.95% | 1,848,786 | $23,424,119 | -269,598 | -12.73% | $12.67 | 13F |
| COGT | Cogent Biosciences Inc | 1.35% | 422,300 | $16,254,327 | -1,976,693 | -82.4% | $38.49 | 13F |
| GERN | Geron Corp | 1.07% | 8,671,797 | $12,920,978 | -18,553,495 | -68.15% | $1.49 | 13F |
| SLNO | Soleno Therapeutics Inc | 0.82% | 294,909 | $9,873,553 | -600,000 | -67.05% | $33.48 | 13F |
| VRDN | Viridian Therapeutics Inc | 0.27% | 166,288 | $3,252,593 | -816,288 | -83.08% | $19.56 | 13F |